WHY THE SAFETY ASSESSMENT OF MARKETED MEDICINES (SAMM) GUIDELINES ARENEEDED

Authors
WALLER PC WOOD SM BRECKENRIDGE AM RAWLINS MD
Citation
Pc. Waller et al., WHY THE SAFETY ASSESSMENT OF MARKETED MEDICINES (SAMM) GUIDELINES ARENEEDED, British journal of clinical pharmacology, 38(2), 1994, pp. 93-93
Citations number
4
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
British journal of clinical pharmacology → ACNP
ISSN journal
03065251
Volume
38
Issue
2
Year of publication
1994
Pages
93 - 93
Database
ISI
SICI code
0306-5251(1994)38:2<93:WTSAOM>2.0.ZU;2-W